ir.genocea.comABOUT GENOCEA — Genocea Biosciences
ir.genocea.com Profile
ir.genocea.com
Maindomain:genocea.com
Title:ABOUT GENOCEA — Genocea Biosciences
Description:The Investor Relations website contains information about Genocea Biosciences business for stockholders, potential investors, and financial analysts.
Discover ir.genocea.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.genocea.com Information
Website / Domain: |
ir.genocea.com |
HomePage size: | 53.575 KB |
Page Load Time: | 0.834391 Seconds |
Website IP Address: |
199.239.182.67 |
Isp Server: |
NTT America Inc. |
ir.genocea.com Ip Information
Ip Country: |
United States |
City Name: |
San Jose |
Latitude: |
37.339389801025 |
Longitude: |
-121.89495849609 |
ir.genocea.com Keywords accounting
ir.genocea.com Httpheader
Accept-Ranges: bytes |
Content-Encoding: gzip |
Content-Language: en |
Content-Type: text/html; charset=UTF-8 |
device: desktop |
ETag: "1588962091" |
Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
Last-Modified: Fri, 08 May 2020 18:21:31 GMT |
Link: http://ir.genocea.com/; rel="shortlink", http://ir.genocea.com/; rel="canonical", https://ir.genocea.com/investor-relations; rel="alternate"; hreflang="en", https://ir.genocea.com/investor-relations; rel="revision" |
Referrer-Policy: no-referrer-when-downgrade |
Server: nginx |
X-Age: 0 |
X-Content-Type-Options: nosniff |
X-Drupal-Dynamic-Cache: UNCACHEABLE |
X-Frame-Options: SAMEORIGIN |
X-Generator: Drupal 8 (https://www.drupal.org) |
X-Request-ID: v-bd7c44a6-9158-11ea-beb7-535b3f58e3f2 |
X-UA-Compatible: IE=edge |
X-XSS-Protection: 1; mode=block |
Content-Length: 12161 |
X-EdgeConnect-MidMile-RTT: 5, 55 |
X-EdgeConnect-Origin-MEX-Latency: 668, 668 |
Cache-Control: public, max-age=0, s-maxage=1800 |
Expires: Fri, 08 May 2020 18:21:31 GMT |
Date: Fri, 08 May 2020 18:21:31 GMT |
Connection: keep-alive |
Vary: Accept-Encoding |
Set-Cookie: SimpleSAMLSessionID=dca8c194aeeba393507eb44c9601593a; path=/; secure; HttpOnly, DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
Strict-Transport-Security: max-age=15768000 ; preload |
ir.genocea.com Meta Info
charset="utf-8"/ |
content="ABOUT GENOCEA — Genocea Biosciences" name="title"/ |
content="Genocea Biosciences" property="og:site_name"/ |
content="index" name="robots"/ |
content="website" property="og:type"/ |
content="The Investor Relations website contains information about Genocea Biosciences business for stockholders, potential investors, and financial analysts." name="description"/ |
content="ABOUT GENOCEA — Genocea Biosciences" name="keywords"/ |
content="no-referrer" name="referrer"/ |
content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
content="width" name="MobileOptimized"/ |
content="true" name="HandheldFriendly"/ |
content="width=device-width, initial-scale=1.0" name="viewport"/ |
199.239.182.67 Domains
ir.genocea.com Similar Website
Domain |
WebSite Title |
bdbiosciences.com | Biosciences | BD Biosciences-US |
fluxionbio.com | Fluxion Biosciences |
research.sanguinebio.com | Sanguine Biosciences |
hbc.ku.edu | About Higuchi Biosciences Center |
qcb.ucla.edu | Institute for Quantitative and Computational Biosciences |
bioflux.fluxionbio.com | Fluxion Biosciences - Cellular Analysis |
ibt.tamhsc.edu | TAMHSC Institute of Biosciences & Technology |
qb3.org | California Institute for Quantitative Biosciences - Wikipedia |
biotecnika.org | BioTecNika – Helps You Make Career in BioSciences Industry |
ibb.rice.edu | IBB | Institute of Biosciences and Bioengineering | Rice University |
netpartner.kcumb.edu | Sign In - Kansas City University of Medicine and Biosciences |
biofuels.dupont.com | Bioenergy | Biofuel Solutions - DuPont Nutrition and Biosciences |
hub.africabiosciences.org | Welcome to Biosciences eastern and central Africa - International Livestock Research Institute (BecA |
ir.genocea.com | ABOUT GENOCEA — Genocea Biosciences |
ir.genocea.com Traffic Sources Chart
ir.genocea.com Alexa Rank History Chart
ir.genocea.com Html To Plain Text
Skip to main navigation Main navigation About Platform Pipeline Investors Genoceans Contact Main navigation About Platform Pipeline Investors Genoceans Contact Investor Relations Overview Press Releases Events & Presentations Governance Highlights Management Team Board of Directors Committee Composition Contact the Board Financials & Filings Financials SEC Filings Annual Reports and proxies Quarterly Results Stock Info Stock Quote & Chart Historic Stock Lookup Analyst Coverage Contact Us Investors ABOUT GENOCEA Genocea is a biopharmaceutical company developing personalized cancer immunotherapies. Our unique ATLAS™ technology platform allows us to identify immunotherapy targets based on each person’s tumor antigen-specific T cell responses. Using ATLAS, we can both optimize neoantigens for inclusion in our immunotherapies and exclude so-called “inhibitory” antigens that appear to exert an immunosuppressive effect on the patient. We are advancing complementary programs built from ATLAS insights: GEN-009, our neoantigen vaccine candidate for which we are conducting a Phase 1/2a clinical trial across a variety of solid tumor types, and GEN-011, our neoantigen-specific adoptive T cell therapy, for which we intend to file an Investigational New Drug Application in the first half of 2020. Stock Quote () Volume Day High Day Low May 8, 2020 2:21 PM EDT Copyright Nasdaq. Minimum 15 minutes delayed. Stock Chart Press Releases Genocea to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid Tumors May 5, 2020 at 4:05 PM EDT Call scheduled for May 12th from 12:00 – 1:30 p.m. EDT CAMBRIDGE, Mass. , May 05, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host a KOL symposium with a live Q&A for analysts and Genocea Provides First Quarter 2020 Corporate Update April 30, 2020 at 7:00 AM EDT Clinical stage programs GEN-009 and GEN-011 continue to advance Anticipate GEN-011 IND filing in Q2 Expect GEN-009 Phase 1/2a Part B readout in Q3 GEN-011 Virtual Symposium planned for May 12 th Conference call today at 8:30 a.m. EDT CAMBRIDGE, Mass. , April 30, 2020 (GLOBE NEWSWIRE) -- Genocea Genocea to Host First Quarter 2020 Corporate Update Conference Call & Webcast April 23, 2020 at 8:01 PM EDT Virtual KOL symposium scheduled for May 12th to review GEN-011 – neoantigen T cell therapy – and the evolving T cell therapy landscape CAMBRIDGE, Mass. , April 23, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen View all news headlines Shareholder Tools Print Page Email Alerts Contact Us RSS News Feeds Search Site - Footer1 About Corporate Overview Management Team Board of Directors Scientific Advisory Board Platform ATLAS Platform Presentations and Publications Pipeline GEN-009 Partnering With Genocea Site - Footer 2 Investors Overview Press Releases Events & Presentations Corporate Governance Financial Filings Stock Information Genoceans Mission Statement Core Values Genoceans at Work Genoceans at Play Become a Genocean Site - Footer3 Contact Genocea 100 Acorn Park Dr Cambridge, MA 02140 Phone: 617.876.8191 Fax: 617.500.0969 CONNECT WITH US TERMS OF USE Back to Top Genocea Biosciences, Inc. Copyright © 2020...
ir.genocea.com Whois
"domain_name": [
"GENOCEA.COM",
"genocea.com"
],
"registrar": "Wild West Domains, LLC",
"whois_server": "whois.wildwestdomains.com",
"referral_url": null,
"updated_date": [
"2020-05-04 18:14:39",
"2020-05-04 18:14:37"
],
"creation_date": "2006-05-03 21:51:01",
"expiration_date": "2021-05-03 21:51:01",
"name_servers": [
"NS03.DOMAINCONTROL.COM",
"NS04.DOMAINCONTROL.COM"
],
"status": [
"clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited",
"clientRenewProhibited https://icann.org/epp#clientRenewProhibited",
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited",
"clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited",
"clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited",
"clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited"
],
"emails": "abuse@wildwestdomains.com",
"dnssec": "unsigned",
"name": null,
"org": "Genocea",
"address": null,
"city": null,
"state": "Massachusetts",
"zipcode": null,
"country": "US"